Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A clinicopathologic variant of multicentric Castleman's disease characterized by thrombocytopenia, ascites (anasarca), microcytic anemia, myelofibrosis, renal dysfunction, and organomegaly
Biomarker and diagnostic research for Castleman-Kojima disease has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Castleman-Kojima disease.
79 publications have been identified in PubMed for Castleman-Kojima disease. Research spans Case Report / Case Series (58%), Review / Meta-Analysis (25%), and Diagnostic / Biomarker (6%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 46 | 58% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 9:42 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Castleman-Kojima disease
20 |
25% |
Testing and diagnosis research | 5 | 6% |
Clinical study results | 3 | 4% |
Disease patterns and progression | 3 | 4% |
Other research | 1 | 1% |
New treatment approaches | 1 | 1% |
Oba Y (2026). [PMID: 41982248](https://pubmed.ncbi.nlm.nih.gov/41982248/). *Clin Kidney J*. [Other]
Parasu T (2026). [PMID: 42153089](https://pubmed.ncbi.nlm.nih.gov/42153089/). *Cureus*. [Case Report / Case Series]
Ono S (2026). [PMID: 41065673](https://pubmed.ncbi.nlm.nih.gov/41065673/). *Modern rheumatology*. [Case Report / Case Series]
Kami W (2026). [PMID: 42178254](https://pubmed.ncbi.nlm.nih.gov/42178254/). *Intern Med*. [Diagnostic / Biomarker]
Suzuki T (2026). [PMID: 42167888](https://pubmed.ncbi.nlm.nih.gov/42167888/). *RMD Open*. [Clinical Trial Publication]
Uribe-Ruíz NA (2026). [PMID: 42174299](https://pubmed.ncbi.nlm.nih.gov/42174299/). *Clin Rheumatol*. [Review / Meta-Analysis]
Ueda Y (2026). [PMID: 41100060](https://pubmed.ncbi.nlm.nih.gov/41100060/). *Rheumatology (Oxford, England)*. [Diagnostic / Biomarker]
Ishigame R (2026). [PMID: 41263524](https://pubmed.ncbi.nlm.nih.gov/41263524/). *Modern rheumatology case reports*. [Case Report / Case Series]
Moyano Navarro JE (2026). [PMID: 42245881](https://pubmed.ncbi.nlm.nih.gov/42245881/). *Cureus*. [Case Report / Case Series]
Mustafa M (2026). [PMID: 41928868](https://pubmed.ncbi.nlm.nih.gov/41928868/). *JCEM Case Rep*. [Case Report / Case Series]